#41: TheMachine: Savient Pharmaceuticals Reports Second Quarter 2008 Financial Results
Conference Call Scheduled for August 7, 2008 at 10:00 a.m. EDT
... |
September 20, 2008
01:19:39 AM |
#40: TheMachine: Savient Announces U.S. Court of Appeals Affirmation of the Dismissal of Securities Class Action Complaint
Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today announced that the... |
July 19, 2008
01:47:35 AM |
#39: TheMachine: Savient Provides Update On Puricase(R) (pegloticase) Biologics License Application
Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today announced an update... |
May 7, 2008
11:29:33 AM |
#38: TheMachine: Savient Pharmaceuticals to Present at 28th Annual Cowen Healthcare Conference on March 18
Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today announced that Paul... |
April 16, 2008
12:41:53 AM |
#37: NewsBot: Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies
Pooled Analysis of Secondary Endpoints Shows Statistical Significance in the... |
December 13, 2007
10:10:26 AM |
#36: NewsBot: SVNT News Savient Pharmaceuticals Reports Fourth Quarter and Year End 2006 Results
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)... |
March 13, 2007
02:46:00 PM |
#35: NewsBot: SVNT News Savient Pharmaceuticals to Hold Fourth Quarter and Year End Financial Results Conference Call on Wednesday, March 14, 2007
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)... |
March 7, 2007
06:24:00 AM |
#34: NewsBot: SVNT News Savient Announces Completion of Patient Enrollment in Phase 3 Trials of Puricase(R) for Treatment-Failure Gout
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)... |
March 6, 2007
09:43:00 AM |
#33: NewsBot: SVNT News Savient Pharmaceuticals Restructures Commercial Operations Following Launch of Authorized Generic
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)... |
January 5, 2007
01:51:00 PM |
#32: NewsBot: SVNT News Savient Pharmaceuticals Announces Launch of Authorized Generic of Oxandrin(R) with Watson Pharmaceuticals
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)... |
December 29, 2006
06:25:00 AM |
#31: NewsBot: SVNT News Savient Pharmaceuticals Announces Appellate Court Decision in Patent Infringement Lawsuit against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)... |
December 12, 2006
03:52:00 PM |
#30: NewsBot: SVNT News Savient Pharmaceuticals Announces Modification of Temporary Restraining Order in Patent Infringement Lawsuit against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:... |
December 11, 2006
06:30:00 AM |
#29: NewsBot: SVNT News Savient Pharmaceuticals Obtains Temporary Restraining Order in Patent Infringement Lawsuit Against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:... |
December 5, 2006
06:08:00 AM |
#28: NewsBot: SVNT News Savient Pharmaceuticals Files Patent Infringement Lawsuit Against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:... |
December 4, 2006
06:00:00 AM |
#27: NewsBot: SVNT News Savient Pharmaceuticals to Present at Lazard Capital Markets Third Annual Life Sciences Conference
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc.... |
November 22, 2006
04:00:00 AM |
| 
| 
| 
| 
| 
| 
